subchapter_subject: "ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS"
part_code: "520"
part_subject: "ORAL DOSAGE FORM NEW ANIMAL DRUGS"
subpart_code: "B"
subpart_subject: "Specific Administrative Rulings and Decisions"
section_number: "520.390b"
section_subject: "Chloramphenicol capsules."
cfr_reference: "21 CFR 520.390b"
title_name: "Title 21"
title_subject: "Food and Drugs"
parts_covered: "Parts 500 to 599"
revised_date: "Revised as of April 1, 2019"
publication_date: "As of April 1, 2019"
contains_description: "Containing a codification of documents of general applicability and future effect"
publication_info: "Published by the Office of the Federal Register National Archives and Records Administration as a Special Edition of the Federal Register"
---
(a)Specifications. Each capsule contains 50, 100, 250, or 500 milligrams (mg) chloramphenicol.
(b)Sponsors. See Nos. 050057 and 054771 in § 510.600(c) of this chapter for use as in paragraph (d) of this section.
(c)Special considerations. Federal law prohibits the extralabel use of this product in food-producing animals.
(d)Conditions of use in dogs—(1) Amount. 25 mg per pound of body weight every 6 hours.
(2)Indications for use. For treatment of bacterial pulmonary infections, bacterial infections of the urinary tract, bacterial enteritis, and bacterial infections associated with canine distemper caused by susceptible organisms.
(3)Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.